Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pharm Res ; 37(10): 195, 2020 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-32944793

RESUMEN

PURPOSE: Design imiquimod-loaded chitosan nanocapsules for transdermal delivery and evaluate the depth of imiquimod transdermal absorption as well as the kinetics of this absorption using Raman Microscopy, an innovative strategy to evaluate transdermal absorption. This nanovehicle included Compritol 888ATO®, a novel excipient for formulating nanosystems whose administration through the skin has not been studied until now. METHODS: Nanocapsules were made by solvent displacement method and their physicochemical properties was measured by DLS and laser-Doppler. For transdermal experiments, newborn pig skin was used. The Raman spectra were obtained using a laser excitation source at 532 nm and a 20/50X oil immersion objective. RESULTS: The designed nanocapsules, presented nanometric size (180 nm), a polydispersity index <0.2 and a zeta potential +17. The controlled release effect of Compritol was observed, with the finding that half of the drug was released at 24 h in comparison with control (p < 0.05). It was verified through Raman microscopy that imiquimod transdermal penetration is dynamic, the nanocapsules take around 50 min to penetrate the stratum corneum and 24 h after transdermal administration, the drug was in the inner layers of the skin. CONCLUSIONS: This study demonstrated the utility of Raman Microscopy to evaluate the drugs transdermal penetration of in the different layers of the skin. Graphical Abstract New imiquimod nanocapsules: evaluation of their skin absorption by Raman Microscopy and effect of the compritol 888ATO® in the imiquimod release profile.


Asunto(s)
Quitosano/farmacocinética , Sistemas de Liberación de Medicamentos/métodos , Ácidos Grasos/farmacocinética , Imiquimod/farmacocinética , Nanocápsulas/administración & dosificación , Piel/metabolismo , Administración Cutánea , Animales , Quitosano/administración & dosificación , Quitosano/química , Ácidos Grasos/administración & dosificación , Ácidos Grasos/química , Imiquimod/administración & dosificación , Imiquimod/química , Nanocápsulas/química , Microscopía Óptica no Lineal/métodos , Absorción Cutánea , Porcinos
2.
Clin Sci (Lond) ; 111(5): 307-17, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16737441

RESUMEN

In the present study, the cytotoxicity of palmitic, stearic, oleic, linoleic, arachidonic, docosahexaenoic and eicosapentaenoic acids on a macrophage cell line (J774) was investigated. The induction of toxicity was investigated by changes in cell size, granularity, membrane integrity, DNA fragmentation and phosphatidylserine externalization by using flow cytometry. Fluorescence microscopy was used to determine the type of cell death (Acridine Orange/ethidium bromide assay). The possible mechanisms involved were examined by measuring mitochondrial depolarization, lipid accumulation and PPARgamma (peroxisome-proliferator-activated receptor gamma) activation. The results demonstrate that fatty acids induce apoptosis and necrosis of J774 cells. At high concentrations, fatty acids cause macrophage death mainly by necrosis. The cytotoxicity of the fatty acids was not strictly related to the number of double bonds in the molecules: palmitic acid>docosahexaenoic acid>stearic acid=eicosapentaenoic acid=arachidonic acid>oleic acid>linoleic acid. The induction of cell death did not involve PPARgamma activation. The mechanisms of fatty acids to induce cell death involved changes in mitochondrial transmembrane potential and intracellular neutral lipid accumulation. Fatty acids poorly incorporated into triacylglycerol had the highest toxicity.


Asunto(s)
Ácidos Grasos/toxicidad , Macrófagos/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Línea Celular , Membrana Celular/efectos de los fármacos , Tamaño de la Célula/efectos de los fármacos , Colorimetría , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ácidos Grasos/farmacocinética , Metabolismo de los Lípidos/efectos de los fármacos , Macrófagos/metabolismo , Macrófagos/patología , Ratones , Necrosis , PPAR gamma/metabolismo , Triglicéridos/metabolismo
3.
Artículo en Inglés | MEDLINE | ID: mdl-11993723

RESUMEN

Research on fatty acid metabolism in cultured human larynx tumor cells Hep2 was carried out. The cells were incubated with either a saturated (palmitic) or a polyunsaturated (linoleic, alpha-linolenic and eicosatrienoic (n-6)) radioactive fatty acid (0.66 pM, 24 h). The best incorporation capacity was observed in the linoleic acid followed by alpha-linolenic, palmitic and eicosatrienoic acids. All fatty acids tested were anabolized to higher derivatives within their own family. Palmitic acid was primarily monodesaturated rather than elongated, proving to have a very active A9 desaturase activity. With respect to polyunsaturated acid metabolism, the conversion of alpha-linolenic acid to higher homologs, although better than linoleic acid, occurred far less efficiently than that observed in other non-highly undifferentiated human tumor cells. This impairment in higher polyunsaturated fatty acid biosynthesis, reflected in the low levels of arachidonic acid in the fatty acid composition, would not reside in the A5 desaturation step since Hep2 cells can readily convert eicosatrienoic acid into arachidonic acid. Considering the potential regulatory role of specific polyunsaturated fatty acids in the cell proliferative control, the knowledge of the metabolism of fatty acids in this human tumor cell would be important for designing future experiments in order to clarify the mechanism involved in balance, proliferation and cell death.


Asunto(s)
Carcinoma Hepatocelular/metabolismo , Ácidos Grasos/metabolismo , Neoplasias Laríngeas/metabolismo , Ácidos Grasos/farmacocinética , Humanos , Células Tumorales Cultivadas
4.
Pharmacol Res ; 42(2): 137-43, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10887042

RESUMEN

D-003 is a mixture of higher primary aliphatic saturated acids purified from sugar cane wax whose main component is octacosanoic acid followed by triacontanoic, dotriacontanoic, and tetratriacontanoic acids. The aim of this study was to evaluate the effects of D-003 on: ex vivo platelet aggregation, arterial thrombosis and bleeding time in rats. In addition, time course of antiplatelet effects of D-003 was also investigated on ex vivo platelet aggregation in guinea-pigs. D-003 (25-200 mg kg(-1)) orally administered at single or repeated doses (3 days) inhibited platelet aggregation induced by collagen (2.2 microg ml(-1)) and ADP (2 micromol l(-1)) in rats, and collagen (0.25 microg ml(-1)) induced aggregation in guinea-pigs in a dose-dependent manner. Single doses of D-003 (5-500 mg kg(-1)) administered orally 2 h before induction of arterial thrombosis significantly inhibited the reduction of rectal temperature. D-003 administered at a single dose (50-200 mg kg(-1)) 2 h before the experiment significantly increased the bleeding time in a dose-dependent manner. The time-course effects of D-003 on platelet aggregation, arterial thrombus formation, and bleeding time showed no effect 0.5 h after dosing, and maximal effects exhibited 1-2 h after treatment, whereas no significant effects were found 4 h after treatment.


Asunto(s)
Ácidos Grasos/farmacología , Fibrinolíticos/farmacología , Inhibidores de Agregación Plaquetaria/farmacología , Adenosina Difosfato/farmacología , Animales , Tiempo de Sangría , Colágeno/farmacología , Relación Dosis-Respuesta a Droga , Ácidos Grasos/farmacocinética , Cobayas , Agregación Plaquetaria/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Trombosis/tratamiento farmacológico
5.
Mol Cell Biochem ; 205(1-2): 13-23, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10821418

RESUMEN

The effects of norepinephrine on ketogenesis in isolated hepatocytes have been reported as ranging from stimulation to inhibition. The present work was planned with the aim of clarifying these discrepancies. The experimental system was the once-through perfused liver from fasted and fed rats. Fatty acids with chain lengths varying from 8-18 were infused. The effects of norepinephrine depended on the metabolic state of the rat and on the nature of the fatty acid. Norepinephrine clearly inhibited ketogenesis from long-chain fatty acids (stearate > palmitate > oleate), but had little effect on ketogenesis from medium-chain fatty acids (octanoate and laureate). With palmitate the decrease in oxygen uptake was restricted to the substrate stimulated portion; with stearate, the decrease exceeded the substrate stimulated portion; with oleate, oxygen uptake was transiently inhibited. Withdrawal of Ca2+ attenuated the inhibitory effects. 14CO2 production from [1-14C]oleate was inhibited. Net uptake of the fatty acids was not affected by norepinephrine. In livers from fed rats, oxygen uptake and ketogenesis from stearate were only transiently inhibited. The conclusions are: (a) in the fasted state norepinephrine reduces ketogenesis and respiration by means of a Ca2+-dependent mechanism; (b) the degree of inhibition varies with the chain length and the degree of saturation of the fatty acids; (c) norepinephrine favours esterification of the activated long-chain fatty acids in detriment to oxidation; (d) in the fed state the stimulatory action of norepinephrine on glycogen catabolism induces conditions which are able to reverse inhibition of ketogenesis and oxygen uptake.


Asunto(s)
Ácidos Grasos/metabolismo , Cetonas/metabolismo , Hígado/efectos de los fármacos , Hígado/fisiología , Norepinefrina/farmacología , Acetoacetatos/metabolismo , Animales , Dióxido de Carbono/metabolismo , Carnitina Aciltransferasas/metabolismo , Relación Dosis-Respuesta a Droga , Ácidos Grasos/farmacocinética , Privación de Alimentos , Hidroxibutiratos/metabolismo , Hígado/metabolismo , Masculino , Oxígeno/metabolismo , Perfusión , Ratas , Ratas Wistar , Albúmina Sérica/farmacología , Estearatos/farmacología , Factores de Tiempo
6.
Mol Cell Biochem ; 143(2): 99-105, 1995 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-7596353

RESUMEN

The aim of this work was to study the fatty acid metabolism of the human-hepatoma cell line Hep G2. The cultured cells were incubated with either a saturated (palmitic, stearic) or a polyunsaturated (linoleic, alpha-linolenic, eicosatrienoic n-6) radioactive fatty acid. The fatty acids were incorporated into all the basic lipid classes as well as into the main phospholipid subclasses in the cellular membranes. All the fatty acids tested provided a source of carbon for lower members of the saturated fatty-acid family or for cholesterol through beta-oxidation and a new cycle of de novo synthesis. Moreover, all radioactive fatty-acid precursors, whether saturated or unsaturated, were anabolized to higher derivatives within their own family. In the case of saturated fatty acids, palmitic and stearic, they were readily monodesaturated to their corresponding products, thus demonstrating the presence of a delta 9 desaturase. Linoleate and alpha-linolenate were both desaturated and elongated to all the subsequent members of their respective n-6 and n-3 families. These latter observations provide evidence for the incidence of desaturation at the 6 and 5 positions along with the existence of an elongating capacity for fatty acids of all families and chain lengths. In addition, the cellular steady-state fatty-acid profile was seen to be significantly different from the spectrum of exogenous fatty acids available in the growth medium. We conclude that the Hep G2 human-hepatoma line represents an appropriate and relevant experimental model system for investigating the fatty-acid metabolism of adult human liver in vivo.


Asunto(s)
Carcinoma Hepatocelular/patología , Ácidos Grasos/metabolismo , Ácidos Grasos/farmacocinética , Ácido 8,11,14-Eicosatrienoico/metabolismo , Animales , Radioisótopos de Carbono , Carcinoma Hepatocelular/química , Carcinoma Hepatocelular/metabolismo , Bovinos , Ácido Graso Desaturasas/metabolismo , Ácidos Grasos/análisis , Ácidos Grasos Insaturados/metabolismo , Ácidos Grasos Insaturados/farmacocinética , Humanos , Ácidos Linoleicos/metabolismo , Ácidos Linoleicos/farmacocinética , Metabolismo de los Lípidos , Lípidos/farmacocinética , Fosfolípidos/análisis , Células Tumorales Cultivadas
7.
J Pediatr ; 125(5 Pt 2): S62-8, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7965455

RESUMEN

Fat digestion and absorption in the infant is a multistep process. An initial gastric phase of lipolysis generates modest amounts of diglycerides, monoglycerides, and free fatty acids. These initial digestion products, as well as bile salts, are required for optimal activity of the intestinal phase of lipolysis. Colipase-dependent pancreatic lipase catalyzes the intraduodenal phase of triglyceride digestion in formula-fed infants; in breast-fed infants this process is also mediated by bile salt-stimulated lipase. Triglyceride fatty acid positional distribution may modulate the efficiency of nutrient absorption. Human milk contains palmitic acid (C16:0) primarily in the sn-2 position; infant formula fat blends contain palmitic acid predominantly in the sn-1 and sn-3 positions. Because pancreatic lipase selectively hydrolyzes triglycerides at the sn-1 and sn-3 positions, free fatty acids and 2-monoglycerides are produced. Free palmitic acid, but not 2-monopalmitin (which is efficiently absorbed), may be lost as a calcium-fatty acid soap in the feces. As a result, many infant formulas contain substantial levels of well-absorbed saturated fatty acids of shorter chain lengths (e.g., C12:0) in place of palmitic acid. Means of increasing the proportion of 2-palmitic acid in infant formula may make possible fat blends closer to that of human milk with acceptable absorption characteristics.


Asunto(s)
Grasas de la Dieta/farmacocinética , Ácidos Grasos Insaturados/farmacocinética , Ácidos Grasos/farmacocinética , Alimentos Infantiles , Fenómenos Fisiológicos Nutricionales del Lactante , Lipasa/metabolismo , Leche Humana/química , Ácidos Palmíticos/metabolismo , Páncreas/metabolismo , Triglicéridos/metabolismo , Animales , Animales Recién Nacidos , Ácidos Grasos/química , Ácidos Grasos Insaturados/química , Humanos , Lactante , Recién Nacido , Absorción Intestinal , Ácido Palmítico , Ratas
8.
J Physiol ; 421: 463-74, 1990 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2348399

RESUMEN

1. Micellar solubilization of lipolytic products is an important step in lipid absorption. However, micelles are not absorbed intact; dissociation of lipolytic products from bile salt micelles must occur. The dissociation of micelles has been postulated to occur in an acidic microclimate. 2. The effect of an acidic microclimate on the uptake of micellar fatty acid was examined in the rat intestine. We reported that the presence of a lower pH microclimate is associated with a higher fatty acid uptake, suggesting that a lower pH enhances fatty acid uptakes from the micelles. 3. Fatty acid uptake from solutions containing a constant amount of bile salt (10 mM) and varying amounts of fatty acid (3.3-26.4 mM) revealed a saturation phenomenon which reflects the fatty acid carrying capacity of a 10 mM-taurocholate solution. 4. There was a linear relationship between fatty acid uptake and fatty acid concentration when the micellar solutions contained a constant ratio of fatty acid and taurocholate (1.32). 5. Our results indicate that the fatty acid carrying capacity of the micelle and the number of micelles in the solution are both important determinants for the amount of fatty acids delivered to the microclimate. The amount of fatty acids derived from the dissociation of micelles within the microclimate determines fatty acid uptake by the intestine.


Asunto(s)
Ácidos Grasos/farmacocinética , Absorción Intestinal/fisiología , Yeyuno/metabolismo , Animales , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Cinética , Masculino , Ácidos Oléicos/farmacocinética , Ratas , Ratas Endogámicas , Ácido Taurocólico/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA